Next Generation News and Research

RSS

Most nurses claim insufficient staffing as the leading cause of their well-being struggles

Cross Country Healthcare, Inc., a market-leading, tech-enabled workforce solutions platform and advisory firm, in collaboration with Florida Atlantic University, today announced the results of its annual survey of nursing professionals and students.

11 May 2023

Targeting uncontrolled inflammation may make tumors more responsive to treatment

Van Andel Institute scientists have pinpointed how a specific gene mutation triggers an inflammatory cascade that may drive development of treatment-resistant cancers.

11 May 2023

Mount Sinai researchers identify a new therapeutic target for MS and other brain disorders

Cross-talk between brain cells and peripheral immune cells can modulate the progression of multiple sclerosis (MS), Mount Sinai researchers have discovered.

8 May 2023

Clinicians must broaden their duty of care while treating people with deep-seated trauma

Child protection experts are imploring clinicians to broaden their duty of care to ensure that patients’ hidden trauma is not overlooked by more obvious physical symptoms and illnesses.

8 May 2023

Study describes a novel, non-destructive method to extract DNA from ancient bone and tooth artifacts

Researchers described a new method to safely release DNA from ancient tooth and bone artifacts.

5 May 2023

Global Access Diagnostics (GADx) welcomes new leadership

GADx announces today that Mr Mark Davis is stepping down as CEO and co-founder after 20 years of unwavering service, having created the organisation Mologic Ltd in June 2003 alongside his father and industry leader, Prof. Paul Davis.

From Global Access Diagnostics 5 May 2023

Exploring the World of RNA Chemistry

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Philip Bevilacqua from Pennsylvania State University about the world of RNA chemistry.

From Pittcon 5 May 2023

Scientists to lead a $15 million project to study how chronic stress can increase cardiovascular risk

Teams of research scientists from three universities will lead an innovative $15 million project to study the biological mechanisms of chronic stress that can increase cardiovascular disease risk.

4 May 2023

Urgent call for improved diagnostics, treatments, and vaccines against deadly Hantavirus

Scientists discuss hantavirus infections, which are a type of viral hemorrhagic fever that can be transmitted to humans through exposure to infected rodents in endemic areas.

30 Apr 2023

New strategy for identifying small molecules offers a promising path for discovering targeted drugs

Scripps Research scientists have developed a new strategy for identifying small molecules that can change the function of proteins, offering a promising path for discovering targeted drugs.

27 Apr 2023

Insomnia drug shows potential as an effective treatment for opioid use disorder

The insomnia drug suvorexant (Belsomra) might be an effective treatment for opioid use disorder, according to a preclinical study from Scripps Research.

27 Apr 2023

MGI secured first corporate order of ultra-high throughput sequencer DNBSEQ-T20×2*

Shanghai, China, April 25th, 2023 — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technology to lead life science, announced its partnership with Shanghai-based JMDNA Biomedical Technology Co., Ltd. (“JMDNA”) for DNBSEQ-T20×2 (“T20”), a sequencer that broke records for its ultra-high throughput and cost-efficiency. This was the first corporate order of the T20 sequencer that MGI has secured worldwide.

From MGI 27 Apr 2023

Developing Next-Generation Nanomaterials for Medical Applications

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Dr. Chad Merkin, Director of the International Institute for Nanotechnology, about his work developing next-generation nanomaterials for medical applications.

From Pittcon 27 Apr 2023

Smoking alters lung microbiome, leading to loss of diversity and community structure

Research investigates the impact of smoking on the lower respiratory tract microbiome. The study found that smoking results in a loss of diversity in the microbiome, changes in co-occurrence patterns, and a weakening of the tight community structure present in healthy microbiomes.

26 Apr 2023

UTEP and TTUHSC El Paso unveil joint initiative to create a pathway for El Paso's future physicians

The University of Texas at El Paso and Texas Tech University Health Sciences Center El Paso today unveiled MedFuture, a joint initiative that will create a pathway for very highly qualified students in our Borderplex to be admitted to attend college and medical school in their hometown of El Paso right out of high school.

25 Apr 2023

New approach to CAR T-cell therapy shows promise against small cell lung cancer in preclinical study

A new approach to chimeric antigen receptor T-cell (CAR T) therapy has shown great promise against small cell lung cancer (SCLC) in a preclinical study.

25 Apr 2023

How alcohol intake contributes to increased pain and hypersensitivity

Chronic alcohol consumption may make people more sensitive to pain through two different molecular mechanisms - one driven by alcohol intake and one by alcohol withdrawal.

21 Apr 2023

New discovery may lead to improved treatments for women with osteoporosis

Van Andel Institute scientists have pinpointed a key driver of low bone density, a discovery that may lead to improved treatments with fewer side effects for women with osteoporosis.

20 Apr 2023

Next-generation vaccine strategies to combat current and emerging SARS-CoV-2 variants

Announcing a new article publication for Zoonoses journal. Vaccines are among the most effective medical countermeasures against infectious diseases.

19 Apr 2023

Unlocking the potential of RNA lipid nanoparticles to revolutionize cancer treatment

This paper discusses the use of RNA lipid nanoparticles for cancer immunotherapy, which has shown promising results in clinical use. However, only a small percentage of patients respond to existing immunotherapies, and the paper explores opportunities for improvement.

18 Apr 2023